{"id":49035,"date":"2022-09-30T16:02:44","date_gmt":"2022-09-30T14:02:44","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/envision-healthcare-provides-best-practices-to-address-americas-devastating-opioid-epidemic\/"},"modified":"2022-09-30T16:02:44","modified_gmt":"2022-09-30T14:02:44","slug":"envision-healthcare-provides-best-practices-to-address-americas-devastating-opioid-epidemic","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/envision-healthcare-provides-best-practices-to-address-americas-devastating-opioid-epidemic\/","title":{"rendered":"Envision Healthcare Provides Best Practices to Address America\u2019s Devastating Opioid Epidemic"},"content":{"rendered":"
\n

\nLeading National Medical Group Releases New White Paper Outlining Clinical Treatment Strategies
\n
<\/i>and Public Policy Recommendations<\/i>\n<\/p>\n

NASHVILLE, Tenn.–(BUSINESS WIRE)–Envision Healthcare, a leading national medical group, released a comprehensive strategy to address America\u2019s pervasive opioid epidemic. Envision\u2019s approach, which is detailed in a new white paper<\/a>, includes clinical treatment recommendations and public policy options based on the extensive medical expertise and leadership of its 25,000 clinicians.\n<\/p>\n

<\/a><\/p>\n

\nAccording to the U.S. Centers for Disease Control and Prevention, more than 932,000 people in the United States have died from a drug overdose since 1999. In 2020 alone, opioids were involved in 68,630 overdose deaths \u2013 nearly 75 percent of all drug overdose deaths. Several factors have exacerbated the opioid crisis in recent years, including the COVID-19 pandemic, which has increased stress-related drug misuse, disrupted recovery meetings and impaired crucial support for at-risk individuals. Additionally, the marked expansion of illicitly manufactured, potent synthetic opioids has flooded the U.S. with lethal counterfeit opioid pain pills, increasing the danger of non-prescribed opioids.\n<\/p>\n

\n\u201cEnvision clinicians have worked for years to safely reduce opioid prescriptions and provide patients with the most clinically appropriate treatment and guidance while setting them up for long-term success,\u201d said Josh Bloomstone, MD, MSc, FASA, SSGB, Senior Vice President of Clinical Innovation and Practice Transformation at Envision Healthcare. \u201cWe are pleased to provide a patient-focused strategy to help stop opioid misuse and abuse and save people\u2019s lives. It will take everyone \u2013 clinicians, public policymakers and community members \u2013 working together to confront this epidemic.\u201d\n<\/p>\n

\nEnvision\u2019s white paper evaluates the appropriate medical treatment to help prevent and treat Opioid Use Disorder, a condition that affects approximately 3 million Americans. The recommendations include specialty-specific tactics to support patients throughout their care journey, including emergency medicine care, surgery, women\u2019s and children\u2019s care and outpatient pain and addiction treatment.\n<\/p>\n

\nThe paper also details advocacy approaches with clinicians and policymakers working to improve patient care. Envision is committed to:\n<\/p>\n